X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6266) 6266
Book Review (1727) 1727
Publication (315) 315
Book Chapter (38) 38
Conference Proceeding (15) 15
Dissertation (8) 8
Magazine Article (6) 6
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
recombinant-human-erythropoietin (5191) 5191
index medicus (4985) 4985
humans (4549) 4549
anemia (2236) 2236
male (2204) 2204
female (2031) 2031
erythropoietin (2014) 2014
erythropoietin - therapeutic use (1848) 1848
urology & nephrology (1519) 1519
middle aged (1463) 1463
recombinant proteins (1411) 1411
adult (1203) 1203
anemia - drug therapy (1177) 1177
aged (1150) 1150
animals (1124) 1124
anemia - etiology (1098) 1098
recombinant human erythropoietin (1003) 1003
erythropoietin - administration & dosage (893) 893
hematology (839) 839
hemodialysis-patients (810) 810
therapy (712) 712
oncology (639) 639
erythropoietin - pharmacology (627) 627
kidney failure, chronic - complications (625) 625
renal dialysis (611) 611
quality-of-life (582) 582
pharmacology & pharmacy (576) 576
kidney failure, chronic - therapy (574) 574
treatment outcome (561) 561
hemodialysis (551) 551
hematocrit (525) 525
double-blind (505) 505
erythropoietin - adverse effects (490) 490
epoetin alfa (461) 461
hematinics - therapeutic use (460) 460
stage renal-disease (454) 454
hemoglobins - analysis (452) 452
hemoglobin (451) 451
medicine, general & internal (451) 451
anemia - blood (448) 448
epoetin-alpha (448) 448
recombinant proteins - therapeutic use (448) 448
transplantation (441) 441
abridged index medicus (438) 438
anemia - therapy (435) 435
chronic-renal-failure (430) 430
disease (424) 424
chronic kidney-disease (398) 398
rats (384) 384
placebo-controlled trial (383) 383
quality of life (379) 379
anaemia (367) 367
blood transfusion (365) 365
cancer (362) 362
dialysis patients (360) 360
hemoglobins - metabolism (357) 357
aged, 80 and over (347) 347
erythropoietin - analogs & derivatives (347) 347
time factors (336) 336
darbepoetin alfa (327) 327
risk factors (327) 327
mice (321) 321
dialysis (314) 314
dose-response relationship, drug (313) 313
erythropoietin - blood (313) 313
prospective studies (309) 309
adolescent (307) 307
chronic disease (301) 301
surgery (298) 298
transfusion (296) 296
mortality (294) 294
pediatrics (293) 293
colony-stimulating factor (291) 291
iron (286) 286
analysis (278) 278
medicine, research & experimental (271) 271
erythropoiesis (270) 270
kidney failure, chronic - blood (267) 267
care and treatment (260) 260
renal dialysis - adverse effects (259) 259
hematinics - administration & dosage (256) 256
chemotherapy (253) 253
retrospective studies (250) 250
chronic kidney disease (244) 244
pharmacokinetics (242) 242
health aspects (235) 235
drug administration schedule (231) 231
erythropoietin - metabolism (231) 231
research (228) 228
injections, subcutaneous (226) 226
darbepoetin-alpha (223) 223
neoplasms - complications (221) 221
cells (220) 220
intravenous iron (217) 217
biochemistry & molecular biology (215) 215
hypertension (215) 215
child (213) 213
erythropoiesis - drug effects (210) 210
injections, intravenous (210) 210
epoetin (208) 208
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5772) 5772
Japanese (146) 146
French (89) 89
Spanish (89) 89
German (83) 83
Chinese (72) 72
Russian (17) 17
Italian (12) 12
Portuguese (10) 10
Korean (9) 9
Polish (7) 7
Czech (2) 2
Croatian (1) 1
Dutch (1) 1
Serbian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Song, J and Wang, XY and Zhu, CL
ANNALS OF NEUROLOGY, ISSN 0364-5134, 12/2016, Volume 80, Issue 6, pp. 952 - 953
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 7, pp. 1040 - 1050
Purpose The efficacy and safety of darbepoetin alfa (DA) for treating patients with active cancer and anemia not receiving or planning to receive cytotoxic... 
SURVIVAL | THERAPY | EFFICACY | ONCOLOGY | TRANSFUSION | RECOMBINANT-HUMAN-ERYTHROPOIETIN | RECEPTOR EXPRESSION | HEMOGLOBIN LEVELS | QUALITY-OF-LIFE | PREVALENCE | EPOETIN-ALPHA
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 03/2019, Volume 73, Issue 3, pp. 297 - 299
Journal Article
Clinical Kidney Journal, ISSN 2048-8505, 2019, Volume 12, Issue 1, pp. 139 - 148
This study evaluated the hemoglobin dose response, other efficacy measures and safety of daprodustat, an orally administered, hypoxia-inducible factor prolyl... 
hemodialysis | chronic kidney disease | daprodustat | recombinant human erythropoietin | anemia
Journal Article
Chemical Science, ISSN 2041-6520, 2019, Volume 10, Issue 3, pp. 815 - 828
The clinical significance of batch-wise variability on the pharmacokinetics and potency of commercial erythropoietin (EPO), prepared recombinantly as a... 
CELLS | COMPLEX | PEPTIDES | RECOMBINANT-HUMAN-ERYTHROPOIETIN | DNA | STRUCTURAL-CHARACTERIZATION | CYSTEINE | RECEPTORS | CHEMISTRY, MULTIDISCIPLINARY | NEOGLYCOPEPTIDES
Journal Article
Blood, ISSN 0006-4971, 10/2013, Volume 122, Issue 17, pp. 2943 - 2964
Journal Article
World Neurosurgery, ISSN 1878-8750, 05/2019, Volume 125, pp. 529 - 530
Journal Article
Separation and Purification Technology, ISSN 1383-5866, 12/2019, Volume 228, p. 115761
In this work, screening of adsorbents for the capture step of recombinant human erythropoietin (rhEPO) purification from human embryonic kidney cells... 
Multicomponent adsorption equilibrium | Multimodal chromatography | Recombinant human erythropoietin | Purification capture step | Ion-exchange chromatography | ENGINEERING, CHEMICAL | PROTEIN ADSORPTION
Journal Article
Critical Care Medicine, ISSN 0090-3493, 12/2009, Volume 37, Issue 12, pp. 3124 - 3157
Journal Article
Circulation, ISSN 0009-7322, 12/2011, Volume 124, Issue 23, pp. e652 - e735
Journal Article